In the randomized, double-blind, phase 3 study, experts explored treatment with neoadjuvant pembrolizumab (Keytruda) plus chemotherapy, followed by adjuvant pembrolizumab, in patients aged 18 years ...

The first patient with advanced gastric and gastroesophageal cancer has been dosed in a trial combining PT886 with ...

First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended by NICE ...

Oncologists never know which patients with dire prognoses will be among the rare, but real responders. The few who defy all ...

Kintara Therapeutics, Inc. ("Kintara") (NASDAQ: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its Board of Directors (the ...

This emphasizes a critical issue as pembrolizumab is increasingly being used in early TNBC and could have long-term survivorship implications. Supported in part by The University of Texas MD Anderson ...

The imaging agent Gleolan is only approved for glioma surgery, so the current trial could lead to a new indication. In this ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

"Exelixis and MSD to trial cancer therapies together in clinical collaboration" was originally created and published by ...

Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic ...

Researchers have discovered that combining immunotherapy and chemotherapy can overcome treatment resistance in a subset of ...